Key findings underscore the need for better control of glycemia, blood pressure and lipid parameters to prevent diabetes-related complications
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
The facility will produce 150 million vaccine doses per year
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets
In a European work-sharing procedure (WSP), Glucophage was approved as the first oral anti-diabetic medication to be used safely from conception to birth
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
Subscribe To Our Newsletter & Stay Updated
